How many insider declarations has Adage Capital Management, L.P. filed?

Adage Capital Management, L.P. has filed 2 public insider declarations with SEC (Form 4).

What is Adage Capital Management, L.P.'s role?

Adage Capital Management, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does Adage Capital Management, L.P. report trades for?

Adage Capital Management, L.P. reports trades for 2 companies, including Solid Biosciences Inc..

What is Adage Capital Management, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 1.8M€ and disposals 969k€.

← Executives ★ Sign in to follow

AC

Adage Capital Management, L.P.

·SEC (Form 4)

Solid Biosciences Inc.Praxis Precision Medicines, Inc.

0

申报总数

0

公司

€182万

▲ 买入（1 笔）

€969,291

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

1

T+90 胜率

0%

T+90 平均收益

-55.0%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the full record of transactions filed by Adage Capital Management, L.P.. Insider active across 2 companies, notably Solid Biosciences Inc.. Cumulatively, 2 reports have been published. Split: 1 buy · 1 sell. Total volume traded: €2.8m. Activity tracked since 18 February 2025. The latest transaction was disclosed on 16 October 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.

Companies and markets linked to Adage Capital Management, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Solid Biosciences Inc. (US)Praxis Precision Medicines, Inc. (US)

申报2 总计

▼

Adage Capital Management, L.P.

高管2025年10月16日Praxis Precision Medicines, Inc.

US$113万10SEC ↗

12,600 股@ US$90.0025100.0% 占其流量Common Stock, $0.0001 par value per share ("Common Stock")SEC:0000902664-25-004455:0

▲

Adage Capital Management, L.P.

高管2025年2月18日Solid Biosciences Inc.

US$191万32SEC ↗

252,545 股@ US$7.56100.0% 占其流量Common Stock, $0.001 par value per shareSEC:0000902664-25-001114:0

标准退出：2025年5月19日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AC

Adage Capital Management, L.P.

·SEC (Form 4)

Solid Biosciences Inc.Praxis Precision Medicines, Inc.

0

申报总数

0

公司

€182万

▲ 买入（1 笔）

€969,291

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

1

T+90 胜率

0%

T+90 平均收益

-55.0%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Explore the full record of transactions filed by Adage Capital Management, L.P.. Insider active across 2 companies, notably Solid Biosciences Inc.. Cumulatively, 2 reports have been published. Split: 1 buy · 1 sell. Total volume traded: €2.8m. Activity tracked since 18 February 2025. The latest transaction was disclosed on 16 October 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.